ACAD
36.55
-0.43
-1.16%
AEMD
1.798
-0.152
-7.7744%
APRI
1.75
-0.02
-1.13%
ARNA
24.53
+0.22
+0.90%
ATEC
2.1
-0.12
-5.41%
CNAT
5.6
-0.09
-1.58%
CRXM
0.163
0.00
0.00%
CYTX
0.346
+0.006
+1.765%
DXCM
69.46
+0.2
+0.29%
GNMK
9.4
-0.25
-2.59%
HALO
16.42
-0.3
-1.79%
ILMN
204.95
-4.45
-2.13%
INNV
0.096
-0.003
-3.3266%
INO
6.07
+0.07
+1.17%
ISCO
1.53
-0.01
-0.65%
ISIS
57.56
0.00
0.00%
LGND
136.18
+1.03
+0.76%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
+0.03
+4.4124%
MEIP
2.69
0.00
0.00%
MNOV
5.47
-0.1
-1.80%
MRTX
10.5
-0.3
-2.78%
MSTX
0.13
-0.01
-5.28%
NBIX
56.33
-0.36
-0.64%
NUVA
53.54
-4.26
-7.37%
ONCS
0.99
0.00
-0.50%
ONVO
2.03
+0.04
+2.01%
OREX
2.33
-0.01
-0.43%
OTIC
3.25
-0.15
-4.41%
QDEL
43.55
+2.64
+6.45%
RCPT
231.96
0.00
0.00%
RGLS
1.32
-0.01
-0.75%
RMD
79.45
-0.08
-0.10%
SCIE
0
0.00
0.00%
SPHS
2.334
+0.012
+0.5254%
SRNE
1.75
-0.1
-5.41%
TROV
0.67
-0.03
-4.29%
VICL
2.4
-0.05
-2.04%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.3
+2.11%
ACAD
36.55
-0.43
-1.16%
AEMD
1.798
-0.152
-7.7744%
APRI
1.75
-0.02
-1.13%
ARNA
24.53
+0.22
+0.90%
ATEC
2.1
-0.12
-5.41%
CNAT
5.6
-0.09
-1.58%
CRXM
0.163
0.00
0.00%
CYTX
0.346
+0.006
+1.765%
DXCM
69.46
+0.2
+0.29%
GNMK
9.4
-0.25
-2.59%
HALO
16.42
-0.3
-1.79%
ILMN
204.95
-4.45
-2.13%
INNV
0.096
-0.003
-3.3266%
INO
6.07
+0.07
+1.17%
ISCO
1.53
-0.01
-0.65%
ISIS
57.56
0.00
0.00%
LGND
136.18
+1.03
+0.76%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
+0.03
+4.4124%
MEIP
2.69
0.00
0.00%
MNOV
5.47
-0.1
-1.80%
MRTX
10.5
-0.3
-2.78%
MSTX
0.13
-0.01
-5.28%
NBIX
56.33
-0.36
-0.64%
NUVA
53.54
-4.26
-7.37%
ONCS
0.99
0.00
-0.50%
ONVO
2.03
+0.04
+2.01%
OREX
2.33
-0.01
-0.43%
OTIC
3.25
-0.15
-4.41%
QDEL
43.55
+2.64
+6.45%
RCPT
231.96
0.00
0.00%
RGLS
1.32
-0.01
-0.75%
RMD
79.45
-0.08
-0.10%
SCIE
0
0.00
0.00%
SPHS
2.334
+0.012
+0.5254%
SRNE
1.75
-0.1
-5.41%
TROV
0.67
-0.03
-4.29%
VICL
2.4
-0.05
-2.04%
VOLC
18
0.00
0.00%
ZGNX
14.55
+0.3
+2.11%
Home » Bio: Guy Servant

Bio: Guy Servant

Guy earned his PhD in Pharmacology in 1996 at the University of Sherbrooke in Sherbrooke, Canada. In 1997, Guy joined Henry R. Bourne’s laboratory at the University of California San Francisco as a post-doctoral fellow. There he made several seminal discoveries on signaling mechanisms regulating GPCR-induced leukocyte chemotaxis, showing that PI-3-Kinase activity plays a pivotal role in the establishment of cell polarity and publishing his results in internationally recognized journals such as Science, Nature Cell Biology, Trends in Cell Biology and Molecular Biology of the Cell. In September 2000 he joined Senomyx as a Scientist and was rapidly promoted through the ranks becoming Senior Director of Assay Development and High Throughput Screening in January 2010. In 2007, Guy’s team discovered the first sweet taste enhancer ever described. Results from this discovery were recently published in Proceedings of the National Academy of Sciences. This significant initial breakthrough subsequently led the development of potent sucralose and sucrose enhancers that will be entering the market in 2011.

Be Sociable, Share!